Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India

被引:83
作者
Gaind, R.
Paglietti, B.
Murgia, M.
Dawar, R.
Uzzau, S.
Cappuccinelli, P.
Deb, M.
Aggarwal, P.
Rubino, S. [1 ]
机构
[1] Univ Sassari, Dept Biomed Sci, Div Expt & Clin Microbiol, I-07100 Sassari, Italy
[2] Safdarjang Hosp, Dept Microbiol, New Delhi, India
[3] Assoc VMMC, New Delhi, India
关键词
Salmonella enterica serovar Paratyphi A; DNA gyrase; topoisomerase IV; integrons; high-level fluoroquinolone resistance;
D O I
10.1093/jac/dkl391
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: To define the genetic characteristics and resistance mechanisms of clinical isolates of Salmonella enterica serovar Typhi (S. Typhi) and S. enterica serovar Paratyphi A (S. Paratyphi A) exhibiting high-level fluoroquinolones resistance. Methods: Three S. Typhi and two S. Paratyphi A ciprofloxacin-resistant isolates (MICs > 4 mg/L) were compared with isolates with reduced susceptibility to ciprofloxacin (MICs 0.125-1 mg/L) by PFGE, plasmid analysis, presence of integrons and nucleotide changes in topoisomerase genes. Results: In S. Typhi and Paratyphi A, a single gyrA mutation (Ser-83 -> Phe or Ser-83 -> Tyr) was associated with reduced susceptibility to ciprofloxacin (MICs 0.125-1 mg/L); an additional mutation in parC (Ser-80 -> Ile, Ser-80 -> Arg, Asp-69 -> Glu or Gly-78 -> Asp) was accompanied by an increase in ciprofloxacin MIC (>= 0.5 mg/L). Three mutations conferred ciprofloxacin resistance: two in gyrA (Ser-83 -> Phe and Asp-87 -> Asn or Asp-87 -> Gly) and one in parC. This is the first report of parC mutations in S. Typhi. Ciprofloxacin-resistant S. Typhi and S. Paratyphi A differed in their MICs and mutations in gyrA and parC. Moreover S. Typhi harboured a 50 kb transferable plasmid carrying a class 1 integron (dfrA15/aadA1) that confers resistance to co-trimoxazole and tetracycline but not to ciprofloxacin. PFGE revealed undistinguishable XbaI fragment patterns in ciprofloxacin-resistant S. Typhi as well as in S. Paratyphi A isolates and showed that ciprofloxacin-resistant S. Typhi have emerged from a clonally related isolate with reduced susceptibility to ciprofloxacin after sequential acquisition of a second mutation in gyrA. Conclusions: To our knowledge this is the first report of molecular characterization of S. Typhi with full resistance to ciprofloxacin. Notably, the presence of a plasmid-borne integron in ciprofloxacin-resistant S. Typhi may lead to a situation of untreatable enteric fever.
引用
收藏
页码:1139 / 1144
页数:6
相关论文
共 30 条
[1]   Laboratory-based surveillance of Salmonella serotype Typhi infections in the United States -: Antimicrobial resistance on the rise [J].
Ackers, ML ;
Puhr, ND ;
Tauxe, RV ;
Mintz, ED .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (20) :2668-2673
[2]   Fluoroquinolone-resistant Salmonella Paratyphi A [J].
Adachi, T ;
Sagara, H ;
Hirose, K ;
Watanabe, H .
EMERGING INFECTIOUS DISEASES, 2005, 11 (01) :172-174
[3]  
Ausubel F.M., 1996, CURRENT PROTOCOLS MO
[4]   Typhoid and paratyphoid fever [J].
Bhan, MK ;
Bahl, R ;
Bhatnagar, S .
LANCET, 2005, 366 (9487) :749-762
[5]   Mutations responsible for reduced susceptibility to 4-quinolones in clinical isolates of multi-resistant Salmonella typhi in India [J].
Brown, JC ;
Shanahan, PMA ;
Jesudason, MV ;
Thomson, CJ ;
Amyes, SGB .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 (05) :891-900
[6]   Expanding drug resistance through integron acquisition by IncFI plasmids of Salmonella enterica typhimurium [J].
Carattoli, A ;
Villa, L ;
Pezzella, C ;
Bordi, E ;
Visca, P .
EMERGING INFECTIOUS DISEASES, 2001, 7 (03) :444-447
[7]   Characterisation of Salmonella spp. mutants produced by exposure to various fluoroquinolones [J].
Cebrian, L ;
Sirvent, E ;
Díaz, JCR ;
Ruiz, M ;
Royo, G .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2003, 22 (02) :134-139
[8]   Drug-resistant Salmonella enterica serotype Paratyphi A in India [J].
Chandel, DS ;
Chaudhry, R ;
Dhawan, B ;
Pandey, A ;
Dey, AB .
EMERGING INFECTIOUS DISEASES, 2000, 6 (04) :420-421
[9]  
Cloeckaert A, 2001, VET RES, V32, P291, DOI 10.1051/vetres:2001105
[10]  
Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346